● Covered by 1 source · 1 reportMedium impact1 negative
Many NHS Trusts Reject Palantir's Federated Data Platform
Key points
- 16 NHS trusts and health boards declared non-use of Palantir's FDP.
- Reasons include existing systems offering similar or better functionality.
- Some trusts found the FDP duplicative or offering limited benefit.
- The UK government faces a decision on a contract break clause.
NHS Trusts Decline Palantir's Data Platform
Numerous NHS organizations across England are rejecting the Federated Data Platform (FDP) developed by Palantir. Freedom of Information (FOI) requests reveal that many health bosses believe they can find better or equal alternatives to the £330m system.
While some health bodies reported benefits like improved waiting list management and surgery scheduling, others, from Gateshead to Truro, have declined its use or reverted to previous systems after trials. One Suffolk trust stated other systems "supercede" the FDP's functionality, and Greater Manchester's care board called it "duplicative" and "retrograde".
Reasons for Rejection
According to over two dozen FOI responses, 16 trusts and health boards have declared they do not use the FDP since its introduction in March 2024. The University Hospitals of North Midlands NHS Trust stated it would not use the system because it "does not appear to provide functionality over and above what we have already."
Dorset HealthCare University Trust confirmed it "will not be adopting or going live with the FDP," and Humber Teaching NHS Foundation Trust has "no plans to use it." Cambridgeshire and Peterborough NHS Foundation Trust noted the system "not offered significant improvements on local systems," and University Hospitals Birmingham NHS Foundation Trust cited "limited expected benefit over existing solutions."
Context and Controversy
The rejections occur as the UK government faces a critical decision regarding a break clause in the seven-year NHS-Palantir deal. This contract was intended to integrate health system data for improved clinical accuracy and efficiency.
Protests against Palantir's involvement in the NHS have also highlighted its contracts with the Israeli military and Donald Trump's homeland security forces. Public concern also exists regarding the company's co-founder, Peter Thiel, who stated in 2023, "The NHS makes people sick."
✨ This summary was generated by AI from the outlets' reporting listed below. It is not independently verified and may contain errors — check the original sources. How BrevFeed works →
The daily brief
One email each morning: the day's tech stories, clustered across outlets and summarized. No account needed.
One email a day. Unsubscribe in one click, any time.
Today's brief
Spend a few minutes, get the whole day. Every topic's top stories in one hands-free rundown — listen, watch, or read the transcript.
▶ Play today's brief
New every morning, and the back catalogue is archived by date.
Reporting from
Multiple NHS organizations in England are declining to use Palantir's £330m Federated Data Platform (FDP), citing that existing systems offer comparable or superior functionality. This rejection comes as the UK government faces a decision on a break clause in its seven-year contract with Palantir, raising questions about the platform's widespread adoption and effectiveness within the NHS.